According to Amryt Pharma's latest financial reports the company has a price-to-book ratio of 2.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 1.44 | -25.65% |
2021-12-31 | 1.94 | -74.7% |
2020-12-31 | 7.66 | 307.37% |
2019-12-31 | 1.88 | -113.02% |
2018-12-31 | -14.4 | -712.08% |
2017-12-31 | 2.36 | 72.81% |
2016-12-31 | 1.36 | 70.35% |
2015-12-31 | 0.8010 | 292.61% |
2014-12-31 | 0.2040 | -84.12% |
2013-12-31 | 1.28 | -62.64% |
2012-12-31 | 3.44 | |
2011-12-31 | N/A | |
2010-12-31 | N/A | |
2009-12-31 | N/A | |
2008-12-31 | N/A | |
2007-12-31 | N/A |